Available Clinical Trials

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355). E-mail: askroswell@roswellpark.org
 

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Principal Investigator: Holtan, Shernan G
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Principal Investigator: Kelly, Kara M
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Principal Investigator: Griffiths, Elizabeth A
Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
Principal Investigator: Fountzilas, Christos
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Principal Investigator: Jain, Prantesh
A Study of ASP3082 in Adults With Advanced Solid Tumors
Principal Investigator: Fountzilas, Christos
Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib
Principal Investigator: Wang, Eunice S
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Principal Investigator: Wang, Eunice S
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
Principal Investigator: Yeary, Karen H
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Principal Investigator: Zsiros, Emese
Belantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant
Principal Investigator: Hillengass, Jens
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
Principal Investigator: Wang, Eunice S
CapTemY90 for Grade 2/3 NET Liver Metastases
Principal Investigator: Iyer, Renuka V
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Principal Investigator: Griffiths, Elizabeth A
Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
Principal Investigator: Hillengass, Jens
Electrotherapy Stimulation Together With Life Coaching for the Support of Burnout Symptoms in Healthcare Workers
Principal Investigator: Gallagher, Amy
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Principal Investigator: Malek, Ehsan
Olanzapine for Managing Anorexia in Head and Neck Cancer Patients Undergoing Chemoradiation, MACRO Trial
Principal Investigator: Singh, Anurag K
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Principal Investigator: Zsiros, Emese
T-Cell Therapy (ECT204) in Adults With Advanced HCC
Principal Investigator: Iyer, Renuka V
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Principal Investigator: McLean, Karen
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
Principal Investigator: Levine, Ellis G
Lamprene Multiple Patient Program
Principal Investigator: Almyroudis, Nikolaos
A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer
Principal Investigator: Krishnamurthy, Anuradha
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
Principal Investigator: Bonaccio, Ermelinda